InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,018.39
(
-0.34%
)
US TECH 100
16,954.40
(
-0.17%
)
Dow Jones
37,903.29
(
0.23%
)
Brent Oil
83.95
(
0.48%
)
Bitcoin
57,540.14
(
-1.20%
)
Post# of 8
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Shizane

Send PM Follow Ignore
Followers 1
Posts 87
Boards Moderated 1
Alias Born 08/14/2013

Shizane

Re: Shizane post# 2

Friday, 08/15/2014 11:32:15 AM

Friday, August 15, 2014 11:32:15 AM

Post# of 8
PURCHASE: ACST @ .95 in the Speculative Plays account.

Expecting this to run up to the end of September 2014.

Top line results from Phase II "TRIFECTA" Trial

to evaluate the safety and efficacy of CaPre(R) in reducing triglyceride levels in patients with mild to severe hypertriglyceridemia

do at end of September 2014.

Acasti Completes Phase II Double Blind (TRIFECTA) and Pharmacokinetic Trials

SHIZANE





*Above statements are wholly my opinion (unless stated otherwise) and should be a taken as such

Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up